Dr Christensen on Azacitidine Plus Venetoclax in AML

Bradley W. Christensen, MD, discusses findings from the phase 3 VIALE-A trial in patients with acute myeloid leukemia.

Related Keywords

Texas ,United States ,Bradleyw Christensen , ,Baylor Charlesa Sammons Cancer Center ,Texas Oncology Baylor Charles ,Cancer Center ,D ,Texas Oncology Baylor Charlesa Sammons Cancer Center ,Nct02993523 ,Vialea Trial ,Patients With Acute Myeloid Leukemia ,